Latest News
-
Wraparound support needed to lose weight and extend longevity
Posted on:
The key to long term weight loss and good health is not just a new, dynamic medication like Ozempic, but a much broader approach involving comprehensive support. This is a view held by leading endocrinologist and senior Kolling Institute researcher Professor Sarah Glastras, who is calling for a shift away from the perception that these
Category:
-
Next generation of researchers to build on remarkable legacy
Posted on:
Leading pain specialist Professor Chris Vaughan has stepped down after a career spanning close to three decades. As a principal hospital scientist, Chris successfully juggled roles as a researcher, mentor and educator at Royal North Shore Hospital, the Kolling Institute and the University of Sydney. He has had a profound impact on the field of
Category:
-
Investing in our Research Pipeline
Posted on:
Three senior clinical research fellows have been appointed as part of an exciting initiative between the University of Sydney and NSLHD to drive activity and build crucial research capability. The group includes audiologist Dr Jacob Pogson, cardiologist Dr Avedis Ekmejian, and physiotherapist Dr Sally Wootton. Northern Sydney (Arabanoo) Precinct, Academic Director Professor James Elliott said
Category:
-
Sydney Health Partners Roadshow heads North
Posted on:
Northern Sydney Local Health District hosted the latest stop on Sydney Health Partners’ 2025 roadshow, Translation in Action. More than 70 researchers and clinicians gathered at the Kolling Institute to hear presentations by colleagues involved in translational research projects, and to see how Sydney Health Partners is assisting research translation. The Kolling’s Academic Director Professor
-
The Kolling welcomes Australia’s leading genomics provider to the institute
Posted on:
Researchers within the Kolling Institute will shortly have the chance to strengthen their genomics capabilities, with AGRF – the Australian Genome Research Facility – establishing a laboratory within the institute. The new lab is part of an exciting partnership between AGRF, the University of Sydney and the Kolling which will see a specialised team and
Category:
-
New study tests how stress and big meals can trigger a heart attack
Posted on:
A heavy Christmas lunch, an argument or even smoke from a bushfire may seem harmless, but for people at risk of heart disease, they could be deadly. A new study is investigating how emotional stress, pollution, chest infections, and large meals can trigger heart attacks in vulnerable people, and importantly, how to manage those triggers
-
Researchers urge caution around breakthrough Alzheimer’s drug
Posted on:
As we live longer and there are more people living into old age, there is an increasing number of people developing dementia with more than 400,000 people currently living with the condition in Australia. Dementia is now the leading cause of death in Australia, and Alzheimer’s disease is the most common cause of dementia. Dementia
Category:
-
New report identifies key health challenges
Posted on:
The latest global health check has confirmed heart disease remains the world’s biggest killer. The concerning trend was identified through the Global Burden of Disease study which analysed health challenges and the leading cause of death in Australia and across the world. The study looked at data over more than three decades from 1990 to
-
National campaign to combat misinformation about osteoarthritis care
Posted on:
Co-inciding with World Arthritis Day (12 October), researchers from the University of Sydney and the Kolling Institue are urging the community to avoid low-value osteoarthritis care, in favour of evidenced-based resources to help manage the condition. Osteoarthritis is the most common form of arthritis and one of the leading causes of disability globally. It affects
Category:
-
September 2025 Kolling NEWS
Posted on:
Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert team of researchers, including some promising progress with our bowel cancer investigators. There’s an opportunity to join a clinical trial to minimise the impact of osteoarthritis, a new approach to reduce spinal cord injury related pain and an international award recognising 40
